I-SMADs (SMAD6 and SMAD7) reside in the nucleus presumably to be sequestered from the TGF-beta receptor complex and thus avoid inappropriate silencing of the signaling pathway. Upon activation of the signaling pathway, I-SMADs exit the nucleus and are recruited to the signaling TGF-beta receptor complex. I-SMADs directly bind to the so-called L45 loop of the type I receptor, the site of binding of R-SMADs. Thus, I-SMADs competitively inhibit the activation/phosphorylation of R-SMADs.
Richardson, MA, Wrana, JL, Gimbrone MA, Jr, Topper, JN, Hayashi, H, Xu, YY, Grinnell, BW, Qiu, Y, Abdollah, S, Falb, D, Cai, J
Nakao, A, Christian, JL, Itoh, S, Nakayama, T, Heldin, NE, Kawabata, M, Moren, A, ten Dijke, P, Afrakhte, M, Heuchel, R, Heldin, CH
© 2022 Reactome
